Maintenance / Service
PRODUCTS
-
UNICORN™ control software offers real-time control of protein purification unit operations (column packing and chromatography) from laboratory bench, through development, to full-scale production. UNICORN™ control system meets the needs of full-scale production with manufacturing systems while maintaining the flexibility needed for method and process development with the range of systems in the ÄKTA™ family.
-
Werum PAS-X as a Service delivers a fully managed, cloud-based MES for pharma and biotech, enabling rapid deployment, scalability, cost savings, compliance, and operational efficiency.
-
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
-
Conduct secure video based visits, manage study schedules, and keep participants connected through a single unified platform.
-
Planning to launch a patient-centric decentralized clinical trial? Give your clinical trial patients an app that makes it easy to participate—from anywhere at any time.
WHITE PAPERS AND CASE STUDIES
-
Enabling Quality By Design
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
Rapid And Robust Preclinical And Clinical Development Of CAR T-Cell Therapies
Streamline CAR T-cell therapy development with integrated support for asset identification, IND submission, early-phase studies, and advanced real-time tracking solutions.
-
The Business Case For EHR eSource In Clinical Trials
Examine how manual data collection challenges prompted the adoption of an eSource solution that streamlined data entry, saving time and costs, reducing errors, and accelerating a multicenter phase 2 trial.
-
How AI Is Unlocking Healthcare Data To Transform Prostate Cancer Treatment
As the global reliance on algorithms and artificial intelligence (AI) continues to grow, the importance of data quality and completeness has become a critical concern.
-
Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs
Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.
-
Using Plant Peptones To Boost Plasmid Yield And Induction
Uncover how Nu‑Tek’s plant-based peptones support E. coli growth, plasmid yield, and controlled induction, offering a sustainable, animal-free alternative for biopharmaceutical cell culture.
-
Pharma Company Digitizes Paper Logbooks To Increase Data Accessibility
A top pharma producer modernized its operations by digitizing paper-based logbooks. Discover how this shift supports compliance and scalability across global manufacturing environments.
-
How GIS Improved Workflows For The Largest Municipal Utility In The U.S.
Read how LADWP updated its workflows and enriched its management of data by implementing a new enterprise-wide GIS platform, based on Esri’s ArcGIS Enterprise, as well as several apps.
-
AMR Drives Exeter-Merritt Growing Water Network
Located in the state of Illinois, Exeter-Merritt Water Cooperative delivers safe and high-quality drinking water to approximately 300 residents from the county of Scott and Morgan. In 2011, the cooperative decided to do a phase 3 expansion and include additional homes in the rural area resulting in connections increasing from 154 to 325. Exeter and Merritt are small rural towns built on hilly terrains and gravel roads, with most of the meters installed in the countryside.
-
How A Biotech Startup Transformed Their Clinical Trial Supply Management
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
Democratize Batch Data Management For AAV Gene Therapies
Explore a biotechnology company's process of choosing a data management solution that offered centralized batch data management, allowing the company to streamline its CMO data delivery process.
-
Phase 1 Clinical Trial Designs And Strategies
With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients.
NEWS
-
Artificial Intelligence For Manufacturing Companies In 2026: SageX Introduces AI Data Transformation Layer To Eliminate Manual ERP Data Entry And Increase Profitability3/5/2026
SageX has announced the expansion of its AI-powered automation platform tailored specifically for manufacturing companies seeking to eliminate manual processes and modernize financial and operational workflows.
-
Shimadzu Introduces i-Series LC-2070/LC-2080 Integrated HPLC Systems11/10/2025
Shimadzu Scientific Instruments announces the launch of the i-Series LC-2070/LC-2080 Integrated High-Performance Liquid Chromatographs (HPLC), the latest evolution of its i-Series line.
-
Immundiagnostik To Highlight Innovative Detection Tools At 2025 ADLM Clinical Lab Expo7/15/2025
Immundiagnostik, Inc., along with its parent company Immundiagnostik AG (Bensheim, Germany), is pleased to announce its upcoming participation at the 2025 ADLM Clinical Lab Expo in Chicago, July 29–31.
-
Sutro Biopharma And Boehringer Ingelheim BioXcellence™ Collaboration: Established First-In-Class Cell-Free Capabilities At Commercial Scale1/7/2025
Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab tazevibulin (luvelta), Sutro’s Tubulin FRα-targeting antibody-drug conjugate (ADC) designed to treat a broad range of patients with ovarian cancer and other FRα expressing cancers.
-
Zymeworks Receives U.S. FDA Fast Track Designation For ZW191, An Frα-Targeting Antibody-Drug Conjugate3/30/2026
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZW191, an antibody-drug conjugate (ADC) targeting folate receptor-α (FRα), for the treatment of patients with advanced or metastatic platinum-resistant ovarian cancer (PROC).